Literature DB >> 16218782

Large-scale production of recombinant viruses by use of a large culture vessel with active gassing.

Takashi Okada1, Tatsuya Nomoto, Toru Yoshioka, Mutsuko Nonaka-Sarukawa, Takayuki Ito, Tsuyoshi Ogura, Mayumi Iwata-Okada, Ryosuke Uchibori, Kuniko Shimazaki, Hiroaki Mizukami, Akihiro Kume, Keiya Ozawa.   

Abstract

Adenovirus and adeno-associated virus (AAV) vectors are increasingly used for gene transduction experiments. However, to produce a sufficient amount of these vectors for in vivo experiments requires large-capacity tissue culture facilities, which may not be practical in limited laboratory space. We describe here a large-scale method to produce adenovirus and AAV vectors with an active gassing system that uses large culture vessels to process labor- and cost-effective infection or transfection in a closed system. Development of this system was based on the infection or transfection of 293 cells on a large scale, using a large culture vessel with a surface area of 6320 cm2. A minipump was connected to the gas inlet of the large vessel, which was placed inside the incubator, so that the incubator atmosphere was circulated through the vessel. When active gassing was employed, the productivity of the adenovirus and AAV vectors significantly increased. This vector production system was achieved by improved CO2 and air exchange and maintenance of pH in the culture medium. Viral production with active gassing is particularly promising, as it can be used with existing incubators and the large culture vessel can readily be converted for use with the active gassing system.

Entities:  

Mesh:

Year:  2005        PMID: 16218782     DOI: 10.1089/hum.2005.16.1212

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  10 in total

1.  Dysregulation of schizophrenia-related aquaporin 3 through disruption of paranode influences neuronal viability.

Authors:  Kazuo Kunisawa; Takeshi Shimizu; Itaru Kushima; Branko Aleksic; Daisuke Mori; Yasuyuki Osanai; Kenta Kobayashi; Anna M Taylor; Manzoor A Bhat; Akiko Hayashi; Hiroko Baba; Norio Ozaki; Kazuhiro Ikenaka
Journal:  J Neurochem       Date:  2018-08-29       Impact factor: 5.372

2.  Protein-anchoring strategy for delivering acetylcholinesterase to the neuromuscular junction.

Authors:  Mikako Ito; Yumi Suzuki; Takashi Okada; Takayasu Fukudome; Toshiro Yoshimura; Akio Masuda; Shin'ichi Takeda; Eric Krejci; Kinji Ohno
Journal:  Mol Ther       Date:  2012-02-28       Impact factor: 11.454

3.  IL-10 gene transfer upregulates arcuate POMC and ameliorates hyperphagia, obesity and diabetes by substituting for leptin.

Authors:  M Nakata; S Yamamoto; T Okada; D Gantulga; H Okano; K Ozawa; T Yada
Journal:  Int J Obes (Lond)       Date:  2015-10-05       Impact factor: 5.095

4.  Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle.

Authors:  Sachiko Ohshima; Jin-Hong Shin; Katsutoshi Yuasa; Akiyo Nishiyama; Junichi Kira; Takashi Okada; Shin'ichi Takeda
Journal:  Mol Ther       Date:  2008-10-21       Impact factor: 11.454

5.  Dopaminergic Signaling in the Nucleus Accumbens Modulates Stress-Coping Strategies during Inescapable Stress.

Authors:  Wanpeng Cui; Tomomi Aida; Hikaru Ito; Kenta Kobayashi; Yusaku Wada; Shigeki Kato; Takashi Nakano; Meina Zhu; Kaoru Isa; Kazuto Kobayashi; Tadashi Isa; Kohichi Tanaka; Hidenori Aizawa
Journal:  J Neurosci       Date:  2020-08-26       Impact factor: 6.167

6.  Focal loss of the paranodal domain protein Neurofascin155 in the internal capsule impairs cortically induced muscle activity in vivo.

Authors:  Kazuo Kunisawa; Nobuhiko Hatanaka; Takeshi Shimizu; Kenta Kobayashi; Yasuyuki Osanai; Akihiro Mouri; Qian Shi; Manzoor A Bhat; Atsushi Nambu; Kazuhiro Ikenaka
Journal:  Mol Brain       Date:  2020-11-23       Impact factor: 4.041

7.  Enhanced cell survival and therapeutic benefits of IL-10-expressing multipotent mesenchymal stromal cells for muscular dystrophy.

Authors:  Yuko Nitahara-Kasahara; Mutsuki Kuraoka; Yuki Oda; Hiromi Hayashita-Kinoh; Shin'ichi Takeda; Takashi Okada
Journal:  Stem Cell Res Ther       Date:  2021-02-04       Impact factor: 6.832

8.  Prophylaxis and treatment of Alzheimer's disease by delivery of an adeno-associated virus encoding a monoclonal antibody targeting the amyloid Beta protein.

Authors:  Masaru Shimada; Shinya Abe; Toru Takahashi; Kazumasa Shiozaki; Mitsue Okuda; Hiroaki Mizukami; Dennis M Klinman; Keiya Ozawa; Kenji Okuda
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

9.  Current Challenges and Future Directions in Recombinant AAV-Mediated Gene Therapy of Duchenne Muscular Dystrophy.

Authors:  Takashi Okada; Shin'ichi Takeda
Journal:  Pharmaceuticals (Basel)       Date:  2013-06-27

10.  Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9.

Authors:  Hironori Okada; Hidetoshi Ishibashi; Hiromi Hayashita-Kinoh; Tomoko Chiyo; Yuko Nitahara-Kasahara; Yukihiro Baba; Sumiko Watanabe; Shin'ichi Takeda; Takashi Okada
Journal:  Mol Ther Nucleic Acids       Date:  2013-05-28       Impact factor: 10.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.